Messenger Biopharma will not develop its own mRNA products and will not produce mRNA.

We are eager to out-license our technologies to pharmaceutical companies for the development of mRNA vaccines and therapies, and to CDMOs for the production of mRNA using at least one of our technologies.

Last news

OST Group becomes a shareholder in July 2019

posted July 08, 2019

Read More

• 1
• 2
• 3
• …
• 7